LinkedIn Profile

Access Neurotez, Inc. historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:neurotezinc.-2 1506083 May 30th, 2019 12:00AM Neurotez, Inc. 269 6.00 Open Biotechnology May 30th, 2019 01:46PM May 30th, 2019 01:46PM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Open Open 990 Highway 22, Suite 200A Bridgewater NJ US 08807 Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 16th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 17th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 18th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 19th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 21st, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 22nd, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 23rd, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 24th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology
private:neurotezinc.-2 1506083 Dec 25th, 2017 12:00AM Neurotez, Inc. 195 6.00 Open Biotechnology Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim. Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.